Latest PAC-1 Stories
Cancer research has truly gone to the dogs as scientists at the University of Illinois have announced the start of phase I trials for a drug showed good results in the treatment of spontaneously occurring cancers in pet dogs.
Researchers have identified a new target for the treatment of lymphoma and are testing a potential new drug in pet dogs afflicted with the disease.
A team of researchers at Virginia Commonwealth University Massey Cancer Center has discovered an entirely new mechanism of action for a novel pharmacological agent currently in clinical trials in patients â€“ the kinase inhibitor BAY 43-9006 â€“ which was designed to disrupt the survival pathways of tumor cells.
- an ornament or knob in the shape of a flower